We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Is Elanco Animal Health (ELAN) Stock Outpacing Its Medical Peers This Year?
Read MoreHide Full Article
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Has Elanco Animal Health Incorporated (ELAN - Free Report) been one of those stocks this year? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.
Elanco Animal Health Incorporated is one of 956 individual stocks in the Medical sector. Collectively, these companies sit at #5 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.
The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. Elanco Animal Health Incorporated is currently sporting a Zacks Rank of #1 (Strong Buy).
Over the past three months, the Zacks Consensus Estimate for ELAN's full-year earnings has moved 6% higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend.
Our latest available data shows that ELAN has returned about 78.5% since the start of the calendar year. In comparison, Medical companies have returned an average of 1.8%. This shows that Elanco Animal Health Incorporated is outperforming its peers so far this year.
Another Medical stock, which has outperformed the sector so far this year, is Eupraxia Pharmaceuticals Inc. (EPRX - Free Report) . The stock has returned 73.2% year-to-date.
The consensus estimate for Eupraxia Pharmaceuticals Inc.'s current year EPS has increased 7.6% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
To break things down more, Elanco Animal Health Incorporated belongs to the Medical - Outpatient and Home Healthcare industry, a group that includes 15 individual companies and currently sits at #39 in the Zacks Industry Rank. This group has gained an average of 10.5% so far this year, so ELAN is performing better in this area.
On the other hand, Eupraxia Pharmaceuticals Inc. belongs to the Medical - Biomedical and Genetics industry. This 470-stock industry is currently ranked #92. The industry has moved +10.5% year to date.
Elanco Animal Health Incorporated and Eupraxia Pharmaceuticals Inc. could continue their solid performance, so investors interested in Medical stocks should continue to pay close attention to these stocks.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Is Elanco Animal Health (ELAN) Stock Outpacing Its Medical Peers This Year?
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Has Elanco Animal Health Incorporated (ELAN - Free Report) been one of those stocks this year? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.
Elanco Animal Health Incorporated is one of 956 individual stocks in the Medical sector. Collectively, these companies sit at #5 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.
The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. Elanco Animal Health Incorporated is currently sporting a Zacks Rank of #1 (Strong Buy).
Over the past three months, the Zacks Consensus Estimate for ELAN's full-year earnings has moved 6% higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend.
Our latest available data shows that ELAN has returned about 78.5% since the start of the calendar year. In comparison, Medical companies have returned an average of 1.8%. This shows that Elanco Animal Health Incorporated is outperforming its peers so far this year.
Another Medical stock, which has outperformed the sector so far this year, is Eupraxia Pharmaceuticals Inc. (EPRX - Free Report) . The stock has returned 73.2% year-to-date.
The consensus estimate for Eupraxia Pharmaceuticals Inc.'s current year EPS has increased 7.6% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
To break things down more, Elanco Animal Health Incorporated belongs to the Medical - Outpatient and Home Healthcare industry, a group that includes 15 individual companies and currently sits at #39 in the Zacks Industry Rank. This group has gained an average of 10.5% so far this year, so ELAN is performing better in this area.
On the other hand, Eupraxia Pharmaceuticals Inc. belongs to the Medical - Biomedical and Genetics industry. This 470-stock industry is currently ranked #92. The industry has moved +10.5% year to date.
Elanco Animal Health Incorporated and Eupraxia Pharmaceuticals Inc. could continue their solid performance, so investors interested in Medical stocks should continue to pay close attention to these stocks.